Australia seems poised to experience potentially transformative treatment for excess weight: Retatrutide. This new dual agonist – working on both GLP-1 and GIP receptors – has promising results in clinical trials, https://retatrutide-australia-we879490.mybjjblog.com/retatrude-australia-the-possibility-for-weight-management-53920819